A construct you can interrogate
The design operation brings the targeting element, receptor-recruiting cluster and linker geometry into one candidate specification. Computed descriptors help examine the proposed construct. The biological question is whether target binding, receptor engagement, uptake and clearance cooperate in the intended setting.
ASGPR-targeting LYTACs are an established research approach. BioTwin’s current contribution is construct composition for a supplied targeting ligand, with the required biological tests kept distinct.
| Question | Familiar approach | BioTwin focus | Practical consequence |
|---|---|---|---|
| Mechanism | Published ASGPR-LYTAC work uses target binding and a GalNAc-based receptor ligand to recruit lysosomal clearance. | Compose the supplied targeting element, GalNAc cluster and a geometry-informed linker. | Assess a concrete construct within a known mechanism. |
| Starting information | The published approach requires a molecule that binds the extracellular target. | The targeting ligand is an input to this operation. | Binder discovery remains a separate job when no suitable ligand exists. |
| Evidence | Published examples include experimental target degradation. | Current construct output provides a design and computed descriptors; uptake and clearance need testing. | Plan assays for each missing step before interpreting target loss. |
This is a comparison of scope and evidence. Each proposed construct needs its own evidence for target binding, uptake and clearance.
Where this can change the program
A team with a suitable extracellular binder can investigate clearance as a different therapeutic job from occupancy alone. The immediate output is a construct to evaluate. Target depletion, receptor dependence and the resulting functional effect remain separate experimental questions.
Check the bridge and the destination
Linker analysis and hepatic-targeting models offer adjacent questions about the construct and its route. A joint analysis must use compatible assumptions; availability of the individual methods does not establish a completed delivery workflow.
- Multi-head geometry · Examine the relationship between linked binding elements. Multi-head geometry
- Hepatic targeting · Distinguish receptor-mediated uptake from hepatic activation. Hepatic targeting